| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 422.00K | 522.00K | 82.00K | 45.00K | 142.00K | 57.00K |
| Gross Profit | -200.00K | 85.00K | 20.00K | 19.67K | 126.50K | 48.00K |
| EBITDA | -7.26M | -7.71M | -8.12M | -6.43M | -2.60M | -1.15M |
| Net Income | -7.38M | -7.88M | -7.81M | -6.50M | -2.61M | -1.26M |
Balance Sheet | ||||||
| Total Assets | 4.79M | 5.98M | 7.59M | 11.22M | 1.45M | 593.00K |
| Cash, Cash Equivalents and Short-Term Investments | 3.46M | 3.95M | 4.86M | 10.37M | 1.27M | 475.00K |
| Total Debt | 163.00K | 1.08M | 575.00K | 162.00K | 0.00 | 3.05M |
| Total Liabilities | 974.00K | 2.12M | 2.07M | 1.24M | 638.00K | 3.47M |
| Stockholders Equity | 3.81M | 3.86M | 5.53M | 9.98M | 807.00K | -2.88M |
Cash Flow | ||||||
| Free Cash Flow | -6.73M | -7.66M | -8.63M | -5.76M | -2.14M | -1.10M |
| Operating Cash Flow | -6.72M | -7.61M | -8.43M | -5.71M | -2.10M | -1.09M |
| Investing Cash Flow | -1.30M | 3.20M | -4.25M | -66.00K | -36.00K | -16.00K |
| Financing Cash Flow | 6.98M | 6.70M | 3.12M | 14.88M | 2.94M | 0.00 |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
49 Neutral | $43.59M | -198.71 | -0.69% | ― | 11.58% | 81.08% | |
49 Neutral | $532.62M | -7.68 | -24.39% | ― | 13.27% | -66.48% | |
47 Neutral | $41.84M | ― | -14.35% | ― | 2.35% | 18.83% | |
43 Neutral | $173.87M | -4.43 | -96.37% | ― | -4.31% | 59.68% | |
41 Neutral | $13.96M | -0.27 | -268.12% | ― | -9.05% | 77.41% | |
41 Neutral | $248.42M | ― | -91.95% | ― | -27.37% | 70.46% |
On October 29, 2025, Wearable Devices Ltd. announced a Securities Purchase Agreement with an institutional investor for a registered direct offering of ordinary shares and pre-funded warrants, expected to raise approximately $3.3 million. This strategic move aims to bolster the company’s working capital and general corporate purposes, potentially enhancing its market position in the AI-powered wearables industry. The offering includes a concurrent private placement of warrants, subject to shareholder approval, and reflects the company’s ongoing efforts to expand its financial resources and operational capabilities.
On October 24, 2025, Wearable Devices Ltd. held its Annual and Special General Meeting of Shareholders, which was initially delayed due to a lack of quorum but later successfully convened. During the meeting, shareholders approved several key proposals, including amendments to the company’s Compensation Policy and an increase in authorized share capital by 450 million ordinary shares. These changes are expected to impact the company’s governance and financial structure, potentially affecting its market positioning and stakeholder interests.
On September 25, 2025, Wearable Devices Ltd. announced the execution of a Sales Agreement with A.G.P./Alliance Global Partners, allowing the company to offer and sell up to $7.4 million of its ordinary shares. The proceeds from these sales are intended for working capital and general corporate purposes. This strategic move is expected to enhance the company’s financial flexibility and support its operational goals, potentially strengthening its position in the wearable technology market.
Wearable Devices Ltd. has announced an Annual and Special General Meeting of Shareholders scheduled for October 24, 2025. The meeting’s agenda includes re-appointing auditors and directors, approving private placements of warrants, amendments to compensation policies, and discussing financial statements. These proposals, if approved, could impact the company’s governance and financial strategies, potentially influencing its market positioning and stakeholder interests.
On September 12, 2025, Wearable Devices Ltd. announced a Securities Purchase Agreement with an institutional investor for a registered direct offering and concurrent private placement, expected to raise approximately $4 million. The offering includes 440,000 ordinary shares and pre-funded warrants, with proceeds intended for working capital and corporate purposes. This move positions the company to strengthen its market presence and operational capabilities, potentially impacting stakeholders by enhancing its financial stability and capacity for innovation.
On September 11, 2025, Wearable Devices Ltd. announced a securities purchase agreement with an institutional investor, involving the issuance of 1,000,000 ordinary shares at $4.00 each, expected to raise approximately $4 million. This offering, along with a concurrent private placement of warrants, aims to bolster the company’s working capital and general corporate purposes, potentially enhancing its market position in the AI-powered wearables industry.
On September 10, 2025, Wearable Devices Ltd. announced that it has secured a U.S. patent for its innovative voice and gesture control technology, which integrates gesture recognition and voice control with biometric authentication. This development positions the company to capture significant market share in consumer electronics and enterprise applications by offering a more natural and intuitive user interaction with smart devices. The patent enhances the company’s intellectual property portfolio and strengthens its leadership in the AI wearables market, promising a more seamless and secure human-machine relationship.
On September 9, 2025, Wearable Devices Ltd. announced that its Board of Directors approved an increase in the number of ordinary shares reserved for issuance under the company’s 2024 Global Equity Incentive Plan. This move increases the share count by 653,760, bringing the total to 795,252 shares. This decision reflects the company’s commitment to expanding its equity incentive plan, which could potentially enhance its ability to attract and retain talent, thereby impacting its operational capabilities and market positioning.